In the media
News
In the media
Driving Innovation In UK Life Sciences
Read full storyPartner news
Vor Biopharma Closes $110 Million Series B Financing
Read full storyPartner news
CVRx Raises $50 Million in New Equity Financing
Read full storyIn the media
Investing in innovation – new digital approaches for a new decade
Read full storyOther news
X-Vax Technology Raises $56 Million in Upsized Series A Financing to Advance Lead Herpes Vaccine Program
Read full storyPress release
Janssen Korea Ltd. and Johnson & Johnson Innovation Announce Launch of Seoul Innovation QuickFire Challenge in Smart Healthcare in Collaboration with Seoul Metropolitan Government and Korea Health Industry Development Institute
Read full storyOther news
Future of healthcare discussions held at Health Horizons in Cambridge
Read full storyOther news
BioTarget Competition: Speeding up the Race to Beat Cancer
Read full storyPress release
Johnson & Johnson Innovation Recognizes Women in STEM2D Joint Project with Griffith University
Read full storyJNJ Press releases
Johnson & Johnson Innovation Opens JLABS @ Shanghai in Collaboration with Shanghai Pharma Engine Company Ltd.
Read full storyPartner news
Provention Bio Announces Closing of Upsized Initial Public Offering
Read full storyPartner news
Asceneuron's Tau Modifier ASN120290 Receives Orphan Drug Designation for Progressive Supranuclear Palsy From the FDA
Read full storyJNJ Press releases
EUSA PHARMA ANNOUNCES ACQUISITION OF GLOBAL RIGHTS TO SYLVANT® (SILTUXIMAB) FROM JANSSEN SCIENCES IRELAND UC FOR $115 MILLION
Read full storyPartner news